Back
75· Active
Health & Science1d 17h ago
The FDA has granted approval to the first adenovirus-based gene therapy for the treatment of adult patients with high-risk bladder cancer unresponsive to traditional BCG therapy.
Silver Spring, Maryland, USA
Who
U.S. Food and Drug Administration (FDA) / Ferring Pharmaceuticals
What
The FDA has granted approval to the first adenovirus-based gene therapy for the treatment of adult patients with high-risk bladder cancer unresponsive to traditional BCG therapy.
When
Sun, 07 Jun 2026 16:50:06 GMT · 1d 17h ago
Where
Silver Spring, Maryland, USA · 39.006°N, 77.032°W
Why
Clinical trial data demonstrated that 51% of patients achieved a complete response within three months, offering an alternative to radical cystectomy.
The Frontline Impact
How this affects you
This provides a critical organ-saving option for cancer patients who previously had few alternatives to major surgery. It marks a significant milestone in the commercial viability of gene therapies for common cancers.
Story chain
1 event in this threadNo related history yet — this is the origin event.
Verified Sources & Citations
Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.